Skip to main content
Year archive

J.B. Chemicals & Pharmaceuticals Lt — 2023 filings

All 207 regulatory filings released by J.B. Chemicals & Pharmaceuticals Lt (JBCHEPHARM) in 2023, sourced directly from the official regulator.

207 Filings
2023 Period
2023 filings (207)
Filing Released Lang
Submission of information of loss of share certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-29 English
Loss of Share Certificates
Regulatory Filings
2023-12-29 English
Closure of Trading Window
Regulatory Filings
2023-12-27 English
Trading Window
Regulatory Filings
2023-12-27 English
Transcript of Investors/Analysts call
Call Transcript
2023-12-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-12-26 English
Updates
Regulatory Filings
2023-12-25 English
Disclosure under Regulation 30 - Receipt of Order
Regulatory Filings
2023-12-25 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2023-12-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-12-22 English
Result of Postal Ballot
Regulatory Filings
2023-12-21 English
Shareholders meeting
Regulatory Filings
2023-12-21 English
Updates
Regulatory Filings
2023-12-20 English
Updates
Legal Proceedings Report
2023-12-20 English
Disclosure under Regulation 30 - Receipt of Order
Regulatory Filings
2023-12-20 English
Disclosure under Regulation 30 - Receipt of order
Regulatory Filings
2023-12-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-12-19 English
Investor Presentation
Investor Presentation
2023-12-19 English
Investor Presentation
Investor Presentation
2023-12-19 English
Conference call for investors and analysts on Friday, December 22, 2023 at 2.30 p.m. IST to discuss Company''s entry into the ophthalmology segment.
Regulatory Filings
2023-12-19 English
Execution of a Trade Mark License Agreement with Novartis Innovative Therapies AG, Switzerland for a portfolio of select ophthalmology brands and promotion & distribution agreement with ....
Regulatory Filings
2023-12-19 English
Acquisition
Regulatory Filings
2023-12-19 English
Resignation
Board/Management Information
2023-12-05 English
Letter of resignation of Mr. Lakshay Kataria who has ceased to be Chief Financial Officer
Regulatory Filings
2023-12-05 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Options Scheme
Share Issue/Capital Change
2023-11-30 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-11-30 English
Newspaper advertisement for Postal Ballot
Regulatory Filings
2023-11-22 English
Copy of Newspaper Publication
Declaration of Voting Results & Voting Rights Announcements
2023-11-22 English
Shareholders meeting
Proxy Solicitation & Information Statement
2023-11-20 English
Postal Ballot Notice
Proxy Solicitation & Information Statement
2023-11-20 English
Updates
Investor Presentation
2023-11-13 English
Presentation
Investor Presentation
2023-11-13 English
Transcript of Investors/Analysts call
Call Transcript
2023-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-11-08 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2023-11-08 English
Copy of Newspaper Publication
Interim / Quarterly Report
2023-11-08 English
Newspaper cutting of extract of consolidated financial results for the quarter and half year ended on September 30, 2023
Interim / Quarterly Report
2023-11-08 English
Disclosure under Regulation 30
Regulatory Filings
2023-11-07 English
Updates
Regulatory Filings
2023-11-07 English
Press Release
Earnings Release
2023-11-07 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-11-07 English
Investor Presentation
Investor Presentation
2023-11-07 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-11-07 English
Allotment of Equity shares on exercise of Stock options pursuant to the Employee Stock Scheme
Share Issue/Capital Change
2023-11-07 English
Grant of Options under Employee Stock Option Scheme
Share Issue/Capital Change
2023-11-07 English
Investor Presentation
Investor Presentation
2023-11-07 English
Press Release
Interim / Quarterly Report
2023-11-07 English
Updates
Capital/Financing Update
2023-11-07 English
Amendment to the Employee Stock Option Scheme
Regulatory Filings
2023-11-07 English
Change in Director(s)
Board/Management Information
2023-11-07 English
Appointment of Non-Executive Director
Board/Management Information
2023-11-07 English
Financial Result Updates
Regulatory Filings
2023-11-07 English
Unaudited financial results for the quarter and half year ended on September 30, 2023 accompanied by limited review report
Regulatory Filings
2023-11-07 English
Investors/Analysts call with management
Regulatory Filings
2023-10-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-10-31 English
Board Meeting — JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of th…
Regulatory Filings
2023-10-30 English
Board Meeting — Financial Results
Regulatory Filings
2023-10-30 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 ,inter alia, to consider and approve unaudited ....
Regulatory Filings
2023-10-30 English
Updates
Regulatory Filings
2023-10-26 English
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-10-26 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-10-09 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants)Regulations, 2018
Regulatory Filings
2023-10-09 English
Closure of Trading Window
Regulatory Filings
2023-09-27 English
Trading Window
Regulatory Filings
2023-09-27 English
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-09-18 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-09-18 English
Press Release
Environmental & Social Information
2023-09-11 English
Press Release on publication of Company''s 2nd Sustainability (ESG) report
Environmental & Social Information
2023-09-11 English
Resignation
Board/Management Information
2023-09-07 English
Resignation of Mr. Lakshay Kataria, Chief Financial Officer and Key Managerial Personnel
Board/Management Information
2023-09-07 English
Submission of Information of Loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-09-06 English
Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-09-06 English
Loss of Share Certificates
Regulatory Filings
2023-09-06 English
Loss of Share Certificates
Regulatory Filings
2023-09-06 English
Loss of Share Certificates
Regulatory Filings
2023-09-06 English
Record Date
Share Issue/Capital Change
2023-08-29 English
Intimation of Record Date for Split/Sub-Division of equity shares
Share Issue/Capital Change
2023-08-29 English
Shareholders meeting
Regulatory Filings
2023-08-25 English
Voting Results of Annual General Meeting held on August 24, 2023 along with Scrutinizer''s Report.
Regulatory Filings
2023-08-25 English
Shareholders meeting
AGM Information
2023-08-24 English
Proceedings of the Annual General Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
AGM Information
2023-08-24 English
Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA
Regulatory Filings
2023-08-23 English
Updates
Regulatory Filings
2023-08-23 English
Transcript of Investors/Analysts call
Call Transcript
2023-08-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-08-16 English
Allotment of equity shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-08-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-08-10 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2023-08-10 English
Copy of Newspaper Publication
Regulatory Filings
2023-08-10 English
Newspaper cutting of extract of consolidated financial results for quarter ended on June 30, 2023
Regulatory Filings
2023-08-10 English
Investor Presentation
Investor Presentation
2023-08-09 English
Press Release
Earnings Release
2023-08-09 English
Investor Presentation
Investor Presentation
2023-08-09 English
Press Release
Earnings Release
2023-08-09 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-08-09 English
Grant of options under Employee stock option scheme
Capital/Financing Update
2023-08-09 English
Outcome of Board Meeting
Capital/Financing Update
2023-08-09 English
Setting-up of proposed step-down subsidiary
Capital/Financing Update
2023-08-09 English
Unaudited Financial Results for the quarter ended on June 30, 2023
Regulatory Filings
2023-08-09 English
Financial Result Updates
Regulatory Filings
2023-08-09 English
Updates
Regulatory Filings
2023-08-08 English
Intimation of schedule of Analysts/Institutional investors meet
Investor Presentation
2023-08-08 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-08-07 English
Allotment of Equity shares on exercise of stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-08-01 English
Investors/analysts call with management
Call Transcript
2023-08-01 English
Board Meeting — JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of th…
Regulatory Filings
2023-08-01 English
Board Meeting — Financial Results
Regulatory Filings
2023-08-01 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 ,inter alia, to consider and approve unaudited ....
Regulatory Filings
2023-08-01 English
Copy of Newspaper Publication
AGM Information
2023-07-29 English
Newspaper advertisement
AGM Information
2023-07-29 English
Updates
Environmental & Social Information
2023-07-28 English
Business Responsibility and Sustainability Report for financial year 2022-23
Environmental & Social Information
2023-07-28 English
Shareholders meeting
AGM Information
2023-07-28 English
Annual Report for financial year 2022-23
Annual Report
2023-07-28 English
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
AGM Information
2023-07-28 English
Submission of Information of loss of share certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-07-22 English
Loss of Share Certificates
Regulatory Filings
2023-07-22 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2023-07-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-13 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-13 English
Copy of Newspaper Publication
AGM Information
2023-06-30 English
Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
Regulatory Filings
2023-06-30 English
Trading Window
Regulatory Filings
2023-06-29 English
Intimation of Trading Window Closure period.
Regulatory Filings
2023-06-29 English
Loss of Share Certificates
Regulatory Filings
2023-06-23 English
Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Regulatory Filings
2023-06-23 English
Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).
AGM Information
2023-06-19 English
Copy of Newspaper Publication
AGM Information
2023-06-19 English
USFDA inspection of Company's manufacturing facility - T20 at Panoli, Gujarat
Regulatory Filings
2023-06-12 English
Updates
Regulatory Filings
2023-06-12 English
Loss of Share Certificates
Regulatory Filings
2023-06-09 English
Submission of Information of loss of share certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-06-09 English
Updates
Regulatory Filings
2023-06-08 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-05-31 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-05-30 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call
Call Transcript
2023-05-30 English
Updates
Regulatory Filings
2023-05-26 English
Intimation of schedule of Analysts/Institutional investors meet
Investor Presentation
2023-05-26 English
Record Date
Notice of Dividend Amount
2023-05-26 English
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Dividend Amount
2023-05-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-05-25 English
Audio recording of Investors/analysts call with Management
Regulatory Filings
2023-05-25 English
Copy of Newspaper Publication
Annual Report
2023-05-25 English
Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2023
Interim / Quarterly Report
2023-05-25 English
Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for half ....
Regulatory Filings
2023-05-24 English
Related Party Transactions
Regulatory Filings
2023-05-24 English
Investor Presentation
Investor Presentation
2023-05-24 English
Investor Presentation
Investor Presentation
2023-05-24 English
Press Release
Earnings Release
2023-05-24 English
Press release on audited consolidated financial results for the quarter and year ended on March 31, 2023
Earnings Release
2023-05-24 English
Stock split
Capital/Financing Update
2023-05-24 English
(I) The Board considered and approved sub-division/split of existing equity shares (ii) Recommended a final dividend of Rs. 9.25 (462.50 %) per equity share
Capital/Financing Update
2023-05-24 English
Financial Result Updates
Regulatory Filings
2023-05-24 English
Dividend
Capital/Financing Update
2023-05-24 English
Outcome of the Board meeting- Audited standalone and consolidate financial results for the year ended on March 31, 2023
Regulatory Filings
2023-05-24 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-05-23 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-05-23 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-22 English
Annual Secretarial Compliance Report for the financial year ended on March 31, 2023.
Regulatory Filings
2023-05-22 English
Investors/analysts call with management
Call Transcript
2023-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-05-17 English
Board Meeting — JB CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2023 to consider and approve the Yearly Audited Financial results of the Comp…
Regulatory Filings
2023-05-08 English
Board Meeting — Stock Split
Regulatory Filings
2023-05-08 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2023-05-08 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve audited financial ....
Regulatory Filings
2023-05-08 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-30 English
Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for financial year 2022-23
Regulatory Filings
2023-04-18 English
Compliance certificate under regulation 7(3) for the year ended March 31, 2023
Regulatory Filings
2023-04-18 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-04-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-04-13 English
Trading Window
Regulatory Filings
2023-03-31 English
Closure of Trading Window
Regulatory Filings
2023-03-31 English
Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Regulatory Filings
2023-03-30 English
Loss of Share Certificates
Regulatory Filings
2023-03-30 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-03-02 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-03-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-02-13 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call
Call Transcript
2023-02-13 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/analysts ....
Call Transcript
2023-02-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-02-09 English
Newspaper cutting of extract of consolidated financial results for quarter ended on December 31, 2022
Interim / Quarterly Report
2023-02-09 English
Copy of Newspaper Publication
Interim / Quarterly Report
2023-02-09 English
Loss of Share Certificates
Regulatory Filings
2023-02-08 English
Record Date
Notice of Dividend Amount
2023-02-08 English
Investor Presentation
Investor Presentation
2023-02-08 English
Press Release
Earnings Release
2023-02-08 English
Issue of duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-02-08 English
Enclosed please find the presentation the Company proposes to make to investors/analysts on performance of the Company for the quarter ended on December 31, 2022.
Investor Presentation
2023-02-08 English
Enclosed please find press release the Company proposes to issue on unaudited consolidated financial results for the quarter ended on December 31, 2022.
Earnings Release
2023-02-08 English
The Company has fixed Saturday, February 18, 2023 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company to receive the interim dividend for FY 2022-2023
Notice of Dividend Amount
2023-02-08 English
Declaration of interim dividend of Rs. 8.50 per share of FV Rs. 2 (425%) for FY 2022-2023
Notice of Dividend Amount
2023-02-08 English
Dividend
Notice of Dividend Amount
2023-02-08 English
Financial Result Updates
Regulatory Filings
2023-02-08 English
Unaudited Financial Results for the quarter ended December 31, 2022
Regulatory Filings
2023-02-08 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2023-02-07 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2023-02-07 English
Investors/analysts call with management
Regulatory Filings
2023-02-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2023-02-01 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve (i) Unaudited ....
Regulatory Filings
2023-02-01 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2023-02-01 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-01-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-01-10 English
Investor Presentation
Investor Presentation
2023-01-10 English
Presentation at JP Morgan Healthcare Conference, SFO US
Investor Presentation
2023-01-10 English